The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/22394
StudyName: Eligibility Multiple Sclerosis, Relapsing-Remitting NCT00530348
Date of export from the portal: 02.07.2020
Date of Upload / last change: 01.06.2017
License: Creative Commons BY 4.0

----

Description: 
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One; ODM derived from: https://clinicaltrials.gov/show/NCT00530348
